Notice of Intent to Publish a Funding Opportunity Announcement for Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R01 )

Notice Number: NOT-DA-17-064

Key Dates

Release Date: December 11, 2017
Estimated Publication Date of Funding Opportunity Announcement :01/08/2018
First Estimated Application Due Date: 02/05/2018
Earliest Estimated Award Date: 07/02/2018
Earliest Estimated Start Date: 08/05/2018

Related Announcements

Issued by

National Institute on Drug Abuse (NIDA)


The National Institute on Drug Abuse (NIDA) intents to reissue the Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R01- Clinical Trial Optional) to solicit applications to support research to deepen our knowledge of the use of synthetic psychoactive drugs, their mechanisms of action, their health effects, and development of prevention strategies and strategies to treat patients in emergency departments and long range treatment.

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and appropriate projects.

The FOA is expected to be published January 2018 with an expected application due date in February 2018.

This FOA will utilize the R01 activity code. Details of the planned FOA are provided below.

Research Initiative Details

This Notice encourages investigators with expertise and insights in the chemistry fields to begin to consider applying for this new FOA.

In addition, collaborative investigations combining expertise in chemistry and pharmacology will be encouraged and these investigators should also begin considering applying for this application.

Among the areas of research encouraged in this initiative are chemical and pharmacological research examining the mechanisms that underlie the effects of psychedelic drug abuse, as well as research designed to improve the translation of existing knowledge of strategies for the prevention and treatment of addiction.

Funding Information

Estimated Total Funding TBD
Expected Number of Awards TBD
Estimated Award Ceiling TBD
Primary CFDA Numbers 93.279

Anticipated Eligible Organizations

Public/State Controlled Institution of Higher Education
Private Institution of Higher Education
Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)
Nonprofit without 501(c)(3) IRS Status (Other than Institution of Higher Education)
Small Business
For-Profit Organization (Other than Small Business)
State Government
Indian/Native American Tribal Government (Federally Recognized)
County governments
City or township governments
Special district governments
Independent school districts
Public housing authorities/Indian housing authorities
Indian/Native American Tribally Designated Organization (Native American tribal organizations (other than Federally recognized tribal governments)
U.S. Territory or Possession
Indian/Native American Tribal Government (Other than Federally Recognized)
Non-domestic (non-U.S.) Entity (Foreign Organization)
Regional Organization

Applications are not being solicited at this time.


Please direct all inquiries to:

Rao Rapaka, PhD
National Institute of General Medical Sciences